Evidence map›Paper›PMID 19822231›Full record

ArticleVaccine2009

Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.

Kenneth L Johnson, Inna G Ovsyannikova, Christopher J Mason, H Robert Bergen, Gregory A Poland

Abstract read
In one paragraph

Article in Vaccine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Towards personalized vaccines.Frontiers in immunology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Current Challenges in Vaccinology.Frontiers in immunology · 2020
    Review
  13. Review
  14. Article
  15. Defending against smallpox: a focus on vaccines.Expert review of vaccines · 2016
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Kenneth L JohnsonMayo Proteomics Research Center, Mayo Clinic, Rochester, MN 55905, United States.
Inna G Ovsyannikova
Christopher J Mason
H Robert Bergen
Gregory A Poland
Mayo Clinic · USMayo Clinic in Arizona · USMayo Clinic in Florida · USWinnMed · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SHUMAN, HOWARD A · 2003 to 2013
$87.6M
NIAID NIH HHS 1-U54-AI-057153NIAID NIH HHS N01 AI040065NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

An important approach for developing a safer smallpox vaccine is to identify naturally processed immunogenic vaccinia-derived peptides rather than live whole vaccinia virus. We used two-dimensional liquid chromatography coupled to mass spectrometry to identify 116 vaccinia peptides, encoded by 61 open reading frames, from a B-cell line (homozygous for HLA class I A*0201, B*1501, and C*03) after infection with vaccinia virus (Dryvax). Importantly, 68 of these peptides are conserved in variola, providing insight into the peptides that induce protection against smallpox. Twenty-one of these 68 conserved peptides were 11 amino acids long or longer, outside of the range of most predictive algorithms. Thus, direct identification of naturally processed and presented HLA peptides gives important information not provided by current computational methods for identifying potential vaccinia epitopes.

Indexed as

Antigen PresentationB-LymphocytesCell Line, TransformedChromatography, LiquidEpitopesHeLa CellsHistocompatibility Antigens Class IHumansPeptidesSmallpoxSmallpox VaccineTandem Mass SpectrometryVacciniaVaccinia virusViral ProteinsEpitopesHistocompatibility Antigens Class IPeptidesSmallpox VaccineViral Proteins

Identifiers

PMID19822231
PMCPMC2787804
OpenAlexW1989457084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.